Trials / Completed
CompletedNCT00157924
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Hypercholesterolemic Patients With Diabetes Mellitus or Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An efficacy and safety study of ezetimibe (+) simvastatin compared to atorvastatin at week 6 in diabetics or metabolic syndrome patients in Korea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | simvastatin (+) ezetimibe | simvastatin (+) ezetimibe 10/20mg. |
| DRUG | atorvastatin | atorvastatin 10mg |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2005-09-12
- Last updated
- 2024-06-07
Source: ClinicalTrials.gov record NCT00157924. Inclusion in this directory is not an endorsement.